HeadUp was developed by Santos Tecnologia. Disclosure A company from Santos, on the coast of São Paulo, developed a helmet that uses infrared light to stimulate areas of the brain and assist in the treatment of mental disorders and neurological diseases. As reported by g1, the equipment is the first medical device developed in Brazil with an exclusive focus on mental health. Called HeadUp, the device uses the transcranial photobiomodulation technique, which uses infrared light to stimulate regions of the brain. Although the technology is already widespread in aesthetic applications, it is new to the Brazilian market for medical devices aimed exclusively at mental health. ? Click here to follow the new g1 Santos channel on WhatsApp.
Helmet developed on the coast of SP helps treat depression, migraines and Alzheimer's; understand
HeadUp was developed by Santos Tecnologia. Disclosure A company from Santos, on the coast of São Paulo, developed a helmet that uses infrared light to stimulate areas of the brain and assist in the treatment of mental...
According to Santos Tecnologia, responsible for developing HeadUp, the investment in the equipment was more than R$10 million. The creation aimed at this type of use was carried out based on studies on the potential of photobiomodulation in the treatment of neurological and psychiatric diseases. For the study, the company entered into partnerships with teaching and research institutions, including the University of Pernambuco (UPE) and the Federal University of Rio Grande do Sul (UFRGS). HeadUp has certifications from the National Health Surveillance Agency (Anvisa) and the National Institute of Metrology, Quality and Technology (Inmetro). The helmet The transcranial photobiomodulation helmet can be used as complementary therapy for: Depression; Anxiety; Migraine; Parkinson's disease; Alzheimer's disease; Other neurological and psychiatric disorders that are still in the clinical research phase. According to neurologist Juarez Harding, the helmet emits low-intensity infrared light, capable of passing through the scalp and reaching brain tissue. The proposal is to stimulate cellular activity and reduce inflammatory processes associated with some neurological diseases. The doctor emphasized that the treatment does not replace conventional therapies and must be indicated by the professional responsible for monitoring the patient. Patient reports experience Receptionist Camila Alves de Carvalho, aged 45, was one of the patients who underwent the photobiomodulation protocol to treat chronic migraines. She said that she faced frequent crises and even sought hospital care several times a week, even taking medication. "After the treatment, I haven't had to go back to the hospital for seven months because of the migraine. I still have occasional pain, like hormonal pain, but the intensity is unmatched," he reported. According to Camila, the frequency of crises decreased by around 70%. "I had crises three or four times a week. Today I have a different quality of life. I work in customer service, and before it was very difficult to continue working during crises." Expansion The company carries out studies at the Clinical Neurology Outpatient Clinic of Cabo de Santo Agostinho, in Pernambuco, to evaluate the use of the equipment in the SUS. According to the company, the device was developed to have low operating costs, be portable and easy to handle clinically, characteristics that could facilitate its large-scale adoption. In addition to operating in the Brazilian market, Santos Tecnologia reported that it maintains scientific exchanges with institutions in the United States, including the University of Massachusetts, with the aim of internationalizing the technology. VIDEOS: g1 in 1 minute Santos
Source: G1
This story was originally published by G1. Visit the original publication for further details.
Open original publication